Literature DB >> 9008624

Complement and complement regulatory proteins in human tears.

M D Willcox1, C A Morris, A Thakur, R A Sack, J Wickson, W Boey.   

Abstract

PURPOSE: The complement system is part of the innate defense system of the body, and it contributes to inflammatory conditions. The current study examined tears for the presence of complement components, the activity of the components, and the presence of regulatory components.
METHODS: The significance of a functional complement system in tears was examined in four ways. First, the presence and concentration of complement components in tear samples (open-eye, closed-eye, and reflex tears) was examined by sandwich enzyme-linked immunosorbent assay. Second, the presence of an active pathway in each tear type was established by supplementation of complement-deficient sera. Third, Western blotting of tear samples was used to determine whether complement components were activated in tears. Fourth, the presence of regulatory components was examined by enzyme-linked immunosorbent assay and by the inhibition of the ability of tears to supplement deficient sera.
RESULTS: Components C1q, C3, factor B, C4, C5, and C9 were detected in closed-eye tears. Only C3, factor B, and C4 were detected in open-eye and reflex tears. Tears were able to supplement complement-deficient sera, indicating that the components were in an active state. Complement components C3, factor B, C4, and C9 were activated in closed-eye tears. The regulatory protein decay-accelerating factor was found only in closed-eye tears. Lactoferrin, another regulatory protein present in all tear types, was shown to inhibit complement-mediated red blood cell lysis, although the inhibition by closed-eye tear lactoferrin was reduced compared to that isolated from other tear types.
CONCLUSIONS: This study has demonstrated that the complement system in tears was functionally active and that the concentration of all components was increased greatly in closed-eye tears. In spite of the presence of regulatory proteins, proteins of the complement cascade in tears were shown to be activated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008624

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

1.  Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

Review 2.  Antimicrobial compounds in tears.

Authors:  Alison M McDermott
Journal:  Exp Eye Res       Date:  2013-07-20       Impact factor: 3.467

3.  RP11 is the second most common locus for dominant retinitis pigmentosa.

Authors:  E Vithana; M Al-Maghtheh; S S Bhattacharya; C F Inglehearn
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

Review 4.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

5.  Tears contain the complement regulator CD59 as well as decay-accelerating factor (DAF).

Authors:  E Cocuzzi; L B Szczotka; W G Brodbeck; D S Bardenstein; T Wei; M E Medof
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

Review 6.  Pathogenesis of acanthamoeba keratitis.

Authors:  Noorjahan Panjwani
Journal:  Ocul Surf       Date:  2010-04       Impact factor: 5.033

Review 7.  The role of complement system in ocular diseases including uveitis and macular degeneration.

Authors:  Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

8.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

9.  Contrast discrimination, non-uniform patterns and change blindness.

Authors:  K C Scott-Brown; H S Orbach
Journal:  Proc Biol Sci       Date:  1998-11-22       Impact factor: 5.349

Review 10.  The role of antimicrobial peptides at the ocular surface.

Authors:  Alison M McDermott
Journal:  Ophthalmic Res       Date:  2008-12-20       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.